Topic: Male Factor Infertility
|
|
|
- Dwain Ira Dean
- 9 years ago
- Views:
Transcription
1 Topic: Male Factor Infertility Topic Overview: Male Factor Infertility Comparisons of pregnancy rates at insemination based on total motile sperm counts from the 1999 and 21 World Health Organization (WHO) semen analysis norms (Dahan) Revisiting DNA integrity in function of sperm motility (Zanko) Age of the sperm donor: does it really matter - an analysis of 1,48,576 assisted reproduction treatment cycles (Ghuman) The quest for the less than ideal spermatozoon does it generate good quality embryos? (Neri) Does body mass index (BMI) influence sperm parameters in infertile men? (Mirallié-Nussbaumer)
2 O-2 Comparisons of pregnancy rates at insemination based on total motile sperm counts from the 1999 and 21 World Health Organization(WHO) semen analysis norms MH Dahan Session 4, Male infertility Study Background and Aim Background For the last 5-years semen analysis norms in the fertile population have been calculated by the WHO and have decreased at each reassessment The 21 WHO manual uses for the first time fertile men as a reference. The 5 th centile was used to calculate the lower limits of normal It could be assumed that this reassessment of limits should have clinical implications, translating into lower pregnancy rates Particularly, if they are to be used for treatment planning in an infertile population Aim To determine whether the 21 semen analysis parameters are better predictors of pregnancy than the 1999 limits when intra uterine inseminations (IUI) are performed. WHO, World Health Organization Dahan MH. Session 4. O-2
3 Study Materials and Methods Retrospective study All semen analysis performed on the day of IUI were enrolled for evaluation (N=2,229) for a period of 2.5 years Fresh semen for IUI was evaluated using a count slide at 37 o C and processed by density gradient, in couples with 1-year of infertility and 1 patent fallopian tube Specimens were categorised by the TMSC and the following groups: 1999 normal: 2 M TMSC 1999 abnormal, but normal by 21: M TMSC 21 abnormal: <7.2 M TMSC TMSC, total motile sperm count Dahan MH. Session 4. O-2 Baseline characteristics of subjects in the three TMSC groups TMSC Normal 1999 N=697 Abnormal 1999 but Normal 21 N=164 Abnormal 21 N=12 Maternal Age (years) Duration of infertility (months) Previous pregnancies 37 ± 6 38 ± 6 37 ±6 23 ± ± ± ± ± ±.9 Number of mature follicles 2.4 ± ± ± 1.1 Max Day 3 FSH (mlu/ml) 7.6 ± ± ± 2.5 FSH, follicle-stimulating hormone Dahan MH. Session 4. O-2
4 Comparison of semen analysis parameters in the three TMSC groups TMSC Normal 1999 N=697 Abnormal 1999 but Normal 21 N=164 Abnormal 21 N=12 Volume (ml) 3.2 ± ± ± 1.9 Concentration (M/mL) 65 ± ± ± 11 Percent motile (%) 57 ± ± ± 12 Total motile sperm count (M) 114 ±17 13 ±4 3.5 ± 2 TMSC, total motile sperm counts Dahan MH. Session 4. O-2 No difference in pregnancy rates between abnormal 1999/normal 21 and the abnormal 21 groups P= Pregnancy Rates Normal 1999 abnormal, 21 normal 21 abnormal A post-hoc analysis found no difference in pregnancy rates between abnormal 1999/normal 21 and the abnormal 21 groups (P=.77), even when correcting for confounding effects Dahan MH. Session 4. O-2
5 Conclusions and Clinical Implications Conclusions Abnormal patients by the 21 guidelines are no less likely to conceive than those who were abnormal by the 1999 limits Therefore, changing these limits has little clinical implications, since only values above the 1999 limits correlate with a higher pregnancy rate Clinical implications Pregnancy rates remain excellent below the 1999 and 21 parameters of normal for TMSC. Therefore controlled ovarian stimulation combined with IUI remains feasible for patients affected with male factor infertility. Dahan MH. Session 4. O-2 O-156 Revisiting DNA integrity in function of sperm motility A Zanko Session 42, Sperm DNA integrity
6 Study Background and Aim Background During the later stages of spermiogenesis, DNA breakages are physiologically induced to allow tight chromatin compaction Only spermatozoa with repaired chromatin reach the ejaculate In the male genital tract, oxygen-free radicals mostly from decaying spermatozoa and other cells are the main cause of DNA damage and responsible for the compromised ART outcome Therefore, tests for sperm DNA integrity are gaining popularity However, sperm chromatin fragmentation does not always correlate with ICSI outcome Aim To revisit the role of DNA fragmentation index (DFI) by measuring the DFI of exclusively motile spermatozoa in relation to clinical outcome. ART, assisted reproductive technology; ICSI, intra-cytoplasmic sperm injection; DFI, DNA Fragmentation index Zanko A. Session 42. O-156 Study Materials and Methods Couples with previous ART failure were screened for sperm DNA fragmentation and inseminated by ICSI DFI was plotted against abstinence period and semen parameters A total of 253 couples with 568 ICSI cycles were analysed and compared DFI was assessed by TUNEL and SCSA tests A normalised DFI (mdfi) was calculated by taking the initial DFI x a constant x motility, and was correlated with clinical outcome Zanko A. Session 42. O-156
7 DFI was positively correlated with abstinence period 7 6 P<.1 Patients with abnormal DFI (%) /262 15/41 1/24 9/19 3 >3 4 >4 5 >5 Abstinence (days) The abstinence period ranged from 1 to 18 days Zanko A. Session 42. O-156 Higher sperm motility had the lowest incidence of DNA fragmentation * *P<.1 DNA fragmentation (%) * 6.3* Initial Immotile Motile Zanko A. Session 42. O-156
8 Clinical pregnancy (%) In women 35 years, mdfi was correlated with ICSI clinical outcome * *P< * DFI mdfi mdfi, but not DFI, was associated with implantation rates and clinical outcomes in women 35 years undergoing ICSI Implantation (%) >25 > >25 >3 Normal Abnormal Normal Abnormal mdfi = DFI x.322 x motility P<.5 DFI mdfi Zanko A. Session 42. O-156 Conclusions and Clinical Implications Conclusions DNA fragmentation positively correlates with abstinence DNA fragmentation inversely correlates with motility When normalised DFI was found to be correlated with ICSI clinical outcome Clinical implications This study indicates that damage to the chromatin is a postspermatogenic phenomenon and it occurs while the sperm is progressing through the male genital tract. Further research in additional studies is required to understand the implications of these findings for clinical practice. Zanko A. Session 42. O-156
9 O-157 Age of the sperm donor: does it really matter - an analysis of 1,48,576 assisted reproduction treatment cycles NK Ghuman Session 42, Sperm DNA integrity Study Background and Aim Background Although it is well known that advanced maternal age has a negative effect on fertility and pregnancy outcome, the influence of paternal age or sperm donor age on these outcomes is less well researched Substantial evidence of reproductive outcome based on male donor age is lacking Aim To determine whether the age of the sperm donor affects the chances of success in women undergoing assisted reproduction for the first time. Ghuman NK. Session 42. O-157
10 Study Materials and Methods UK Human Fertilisation and Embryology Authority (HFEA) data registry from year 1991 to 212 1,48,576 treatment cycles analysed 237,853 sperm donation cycles 39,282 first sperm donation treatment cycles in selected groups, i.e. women aged years and women >37 years Ghuman NK. Session 42. O-157 Study Materials and Methods (con t.) 3,97 cycles in year women 9,185 cycles in >37 years women 25,925 DI cycles 4172 IVF/ICSI cycles 649 DI cycles 2695 IVF/ICSI cycles Above groups were sub-divided in 6 sub-groups based on sperm donor age (<2, 21 25, 26 3, 31 35, 36 4 and years) Regression Logistics was applied to compare Live births in sub-groups in all four groups separately IVF, in-vitro fertilisation; DI, donor insemination Ghuman NK. Session 42. O-157
11 Age of the sperm donor does not alter the live birth rate in females undergoing ART Live birth rate (%) % 28.3% 17% 16.6% 11% 12% 9.7% * 3.1% 4.6% < Sperm donor age group (years) years women IVF/ICSI treatment cycles >37 years women IVF/ICSI treatment cycles years women DI cycles >37 years women DI cycles Impact of sperm donor age on live birth failed to reach statistical significance in any of the age groups Ghuman NK. Session 42. O-157 Conclusions and Clinical Implications Conclusions Age of the sperm donor does not significantly alter the live birth rate in females undergoing ART As the study is based on available data registry, potential confounders such as smoking, body mass index were not accounted There was no follow-up of the children Clinical implications This is probably the first study to conduct an analysis of impact of sperm donor age on live birth using a large national database. Although female age is a key predictor of outcome in ART, sperm donor age appears to have less of an impact on outcome. Ghuman NK. Session 42. O-157
12 O-16 The quest for the less than ideal spermatozoon does it generate good quality embryos? QV Neri Session 42, Sperm DNA integrity Study Background and Aim Background Cryptozoospermic and azoospermic men often provide scarce and dysmorphic spermatozoa plagued by poor motility The genomic integrity and competence of these spermatozoa are of concern In pseudo-/azoo-spermic men, an extensive search is required to find suitable spermatozoa to be injected The increasing search time is inversely related to sperm availability, morphology, kinetic characteristics and genomic integrity Aim To assess the clinical outcome of less than ideal spermatozoa identified in ejaculated and testicular specimens. Neri QV. Session 42. O-16
13 Study Materials and Methods In a retrospective cohort analysis, ICSI outcomes were reviewed as a function of the length of microscopic sperm search carried out in ejaculated (n=2197) and testicular specimens (n=118) Fertilisation, pregnancies, deliveries, and child health in relation to increasing search time were compared to controls with a large selection of spermatozoa An extended sperm quest of ejaculated and TESE samples was performed The genomes of the sperm were screened TESE, testicular sperm extraction Neri QV. Session 42. O-16 Trend towards decreasing fertilisation rates with increased search time Fertilisation (%) Ejaculated TESE Control 3 6 min min min >18 min Search time Neri QV. Session 42. O-16
14 A strenuous search for the male gamete is rewarded by the achievement of pregnancy 8 Ejaculated 8 TESE 7 7 Clinical pregnancy (%) Control 3 6 min min min 5 >18 min Clinical pregnancy (%) Control 3 6 min min min 22.7 >18 min Search time Search time Neri QV. Session 42. O-16 Morphologically and kinetically impaired spermatozoa affect fertilisation but not embryo developmental competence Percentage Ejaculated * Motile 8 7 *P=.1 Immotile 59.1* * Percentage * 2 TESE * P=.1 Motile Immotile Fertilization Clinical Pregnancy Delivery/Ongoing Fertilization Clinical Pregnancy Delivery/Ongoing Neri QV. Session 42. O-16
15 Conclusions and Clinical Implications Conclusions An exhaustive sperm quest in specimens from men with severely compromised spermatogenesis yielded morphologically and genomically impaired spermatozoa that retained the ability to activate oocytes This can only be explained by the ability of the oocyte to overcome eventual male genomic errors Clinical implications With ICSI, the ability to achieve a pregnancy appears to be relatively unaffected by the abating quality and scarcity of spermatozoa retrieved. Neri QV. Session 42. O-16 O-17 Does body mass index influence sperm parameters in infertile men S Mirallié-Nussbaumer Session 4, Male infertility
16 Study Background and Aim Background Extreme BMI categories, i.e. underweight and obese categories, are known to negatively impact female fertility and ART success rates In men, the evidence is not as clear Some researchers have shown that male obesity leads to altered semen parameters and lower success rates in ART cycles Aim To investigate the correlation between BMI and semen parameters in a population of unselected subfertile men. Mirallié-Nussbaumer S. Session 4. O-17 Study Materials and Methods Prospective monocentric study All men who came for a first routine fertility evaluation at the andrology laboratory received a questionnaire dealing with various demographic characteristics Participants were classified into four groups according to their BMI: <18.5 kg/m kg/m kg/m 2 >3 kg/m 2 Sperm analysis was performed with strict adherence to WHO 5th edition recommendations Kinetic parameters were assessed with a CASA system CASA, computer-aided semen analyser Mirallié-Nussbaumer S. Session 4. O-17
17 CASA kinetic parameters were comparable in all BMI groups Abstinence delay was comparable in all groups CASA kinetic parameters (VCL, VSL, ALH) were not significantly different among the 4 BMI groups Mean volume of the ejaculate, sperm concentration, total sperm numeration, and morphology were not significantly different among the 4 BMI groups VCL, curvilinear velocity; VSL, straight-line velocity; ALH, amplitude of lateral head displacement Mirallié-Nussbaumer S. Session 4. O-17 Mean progressive motility was significantly lower in underweight men Progressive motility Percentage *P< * Underweight (n=18) Normoweight (n=769) Overweight (n=385) Obese (n=94) However, the population of underweight men was limited Mirallié-Nussbaumer S. Session 4. O-17
18 Conclusions and Clinical Implications Conclusions Contrary to what has already been described in other studies, this study did not find any significant difference in terms of conventional sperm parameters and CASA parameters between obese, overweight and normoweight infertile men However, progressive sperm motility was significantly lower in underweight men compared with other categories Clinical implications The issue of the correlation between BMI and sperm parameters in infertile men remains to be fully addressed. A specific focus in future studies should be put on underweight infertile men, as they might constitute a particular patient subgroup. Mirallié-Nussbaumer S. Session 4. O-17 Summary
19 Summary: Male Factor Infertility Dahan et al: Pregnancy rates remain excellent below the 1999 and 21 WHO parameters of normal for TMSC Therefore controlled ovarian stimulation combined with IUI remains feasible for patients affected with male factor infertility Zanko et al: Damage to the chromatin is a post-spermatogenic phenomenon and it occurs while the sperm is progressing through the male genital tract Further research in additional studies is required to understand the implications of these findings for clinical practice Ghuman et al: Age of the sperm donor does not significantly alter the live birth rate in females undergoing ART Summary: Male Factor Infertility (con t.) Neri et al: An exhaustive sperm quest in specimens from men with severely compromised spermatogenesis yielded morphologically and genomically impaired spermatozoa that retained the ability to activate oocytes This can only be explained by the ability of the oocyte to overcome eventual male genomic errors Mirallié-Nussbaumer et al: The issue of the correlation between BMI and sperm parameters in infertile men remains to be fully addressed A specific focus in future studies should be put on underweight infertile men, as they might constitute a particular patient subgroup
Clinical Policy Committee
Northern, Eastern and Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group Clinical Policy Committee Commissioning policy: Assisted Conception Fertility assessment
Tower Hamlets CCG Fertility policy
Tower Hamlets CCG Fertility policy Approved December 2014 Introduction Tower Hamlets CCG is responsible for commissioning a range of health services including hospital, mental health and community services
East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception. December 2014
East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception December 2014 1 1. Introduction This policy sets out the entitlement and service that will
Clinical Reference Group Quality & Safety Committee Governing Body. Policy Screened
Fertility Policy 1 SUMMARY This policy is intended to support individuals and couples who want to become parents but who have a possible pathological problem (physical or psychological) leading to them
The relevant NICE Clinical Guidance 156, Fertility can be accessed here: http://www.nice.org.uk/guidance/cg156
City and Hackney CCG Fertility policy Approved January 2015 Introduction City and Hackney CCG is responsible for commissioning a range of health services including hospital, mental health and community
Assisted Reproductive Technologies at IGO
9339 Genesee Avenue, Suite 220 San Diego, CA 92121 858 455 7520 Assisted Reproductive Technologies at IGO Although IGO no longer operates an IVF laboratory or program as such, we work closely with area
Final Version Two (Sept 2014) Eastern Cheshire Clinical Commissioning Group NHS Funded Treatment for Subfertility Policy
Final Version Two (Sept 2014) Eastern Cheshire Clinical Commissioning Group NHS Funded Treatment for Subfertility Policy NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA Table of Contents 1.
Symposium on RECENT ADVANCES IN ASSISTED REPRODUCTIVE TECHNOLOGY
Symposium on RECENT ADVANCES IN ASSISTED REPRODUCTIVE TECHNOLOGY Dr Niel Senewirathne Senior Consultant of Obstetrician & Gynaecologist De zoyza Maternity Hospita 1 ART - IVF & ICSI 2 Infertility No pregnancy
How To Get A Refund On An Ivf Cycle
100% IVF Refund Program Community Hospital North Clearvista Dr. N Dr. David Carnovale and Dr. Jeffrey Boldt, along with everyone at Community Reproductive Endocrinology, are committed to providing you
Standardising Access Criteria to NHS Fertility Treatment FOR COMMISSIONERS OF FERTILITY SERVICES
Standardising Access Criteria to NHS Fertility Treatment FOR COMMISSIONERS OF FERTILITY SERVICES Status of the document This document offers guidance to help PCTs move towards more equitable provision
Fertility Facts and Figures 2008
Fertility Facts and Figures 2008 Contents About these statistics... 2 Accessing our data... 2 The scale of fertility problems... 3 Treatment abroad... 3 Contacts regarding this publication... 3 Latest
Assisted Conception Policy. February 2016. Dr. Liz Saunders Cyril Haessig
Assisted Conception Policy February 2016 Dr. Liz Saunders Cyril Haessig CONTENTS Executive Summary... 3 Policy outline... 5 Detailed criteria... 8-2 - ASSISTED CONCEPTION COMMISSIONING POLICY EXECUTIVE
ASSISTED REPRODUCTIVE TECHNOLOGIES (ART)
ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) Dr. Herve Lucas, MD, PhD, Biologist, Andrologist Dr. Taher Elbarbary, MD Gynecologist-Obstetrician Definitions of Assisted Reproductive Technologies Techniques
Lesbian Pregnancy: Donor Insemination
Lesbian Pregnancy: Donor Insemination (Based on an article originally published in the American Fertility Association 2010 National Fertility and Adoption Directory. Much of this information will also
IVF OVERVIEW. Tracy Telles, M.D.
IVF OVERVIEW By Tracy Telles, M.D. Dr. Hendler: Hello and welcome to KP Healthcast. I m your host Dr. Peter Hendler and today our guest is Dr. Tracy Telles. Dr. Telles is an IVF physician in Kaiser Walnut
IVF MONEY-BACK PLAN IN PARTNERSHIP WITH
IVF MONEY-BACK PLAN IN PARTNERSHIP WITH Programmes Refund Programme Up to 3 fresh cycles of IVF/ICSI and all frozen embryo transfers Available to women under 40 years old Medical Review required for all
FERTILITY AND AGE. Introduction. Fertility in the later 30's and 40's. Am I fertile?
FERTILITY AND AGE Introduction Delaying pregnancy is a common choice for women in today's society. The number of women in their late 30s and 40s attempting pregnancy and having babies has increased in
Infertility Services Medical Policy For University of Vermont Medical Center and Central Vermont Medical Center employer groups
Infertility Services Medical Policy For University of Vermont Medical Center and Central Vermont Medical Center employer groups File name: Infertility Services File code: UM.REPRO.01 Last Review: 02/2016
London Fertility Centre Price List
London Fertility Centre Price List Fertility Testing Packages Standard Female fertility testing package AMH Ultrasound scan 15 minute doctor consultation to discuss your results Premium Female fertility
Welcome to chapter 2. The following chapter is called "Indications For IVF". The author is Dr Kamini A. Rao.
Welcome to chapter 2. The following chapter is called "Indications For IVF". The author is Dr Kamini A. Rao. The indications for an IVF treatment have increased since the birth of the first IVF baby. The
OHTAC Recommendation. In Vitro Fertilization and Multiple Pregnancies
OHTAC Recommendation In Vitro Fertilization and Multiple Pregnancies October 19, 2006 The Ontario Health Technology Advisory Committee (OHTAC) met on October 19, 2006 and reviewed the health technology
In - Vitro Fertilization Handbook
In - Vitro Fertilization Handbook William F. Ziegler, D.O. Medical Director Scott Kratka, ELD, TS Embryology Laboratory Director Lauren F. Lucas, P.A.-C, M.S. Physician Assistant Frances Cerniak, R.N.
Reproductive Technology. Chapter 21
Reproductive Technology Chapter 21 Assisted Reproduction When a couple is sub-fertile or infertile they may need Assisted Reproduction to become pregnant: Replace source of gametes Sperm, oocyte or zygote
Guide to IVF Laboratory Results
Guide to IVF Laboratory Results PACIFIC CENTRE FOR REPRODUCTIVE MEDICINE 500-4601 Canada Way, Burnaby BC V5G 4X7 LAB-416-20140122-1 The following information will guide you through what results to expect
Artificial insemination
Artificial insemination What is involved? Artificial insemination is an assisted reproduction technique that consists of inserting laboratory-treated spermatozoa into the woman s uterus or cervical canal.
Authorized By: Holly C. Bakke, Commissioner, Department of Banking and Insurance.
INSURANCE DIVISION OF INSURANCE Actuarial Services Benefit Standards for Infertility Coverage Proposed New Rules: N.J.A.C. 11:4-54 Authorized By: Holly C. Bakke, Commissioner, Department of Banking and
Assignment Discovery Online Curriculum
Assignment Discovery Online Curriculum Lesson title: In Vitro Fertilization Grade level: 9-12, with adaptation for younger students Subject area: Life Science Duration: Two class periods Objectives: Students
How to choose an IVF clinic and understand success rates: Questions to ask when choosing an IVF clinic.
Australia s National Infertility Network How to choose an IVF clinic and understand success rates: Questions to ask when choosing an IVF clinic. updated 26 05 2015 20 The information contained here is
OUR IVF/ICSI PROGRAMME
OUR IVF/ICSI PROGRAMME The Manzanera Fertility Clinic has designed a simple fertility programme that aims to be convenient for couples living outside of Spain while maximising your chances of success.
SO, WHAT IS A POOR RESPONDER?
SO, WHAT IS A POOR RESPONDER? We now understand why ovarian reserve is important and how we assess it, but how is poor response defined? Unfortunately, there is no universally accepted definition for the
Minimum standards for ICSI use, screening, patient information and follow-up in WA fertility clinics. January 2006
Minimum standards for ICSI use, screening, patient information and follow-up in WA fertility clinics January 2006 1. BACKGROUND ICSI has been shown to be effective for male factor infertility and it also
HOW IS OVARIAN RESERVE ASSESSED?
HOW IS OVARIAN RESERVE ASSESSED? The majority of indicators we have to assess OR assess egg quantity rather than egg quality and these two do not always go hand in hand. No individual test is a perfect
Illinois Insurance Facts Illinois Department of Financial and Professional Regulation Division of Insurance
Illinois Insurance Facts Illinois Department of Financial and Professional Regulation Division of Insurance Insurance Coverage for Infertility Treatment Revised November 2004 Infertility is a condition
Egg and sperm donation in the UK: 2012 2013
Egg and sperm donation in the UK: 2012 2013 Contents Introduction 2 Background to this report 2 Terms and acronyms used in this report 4 Methodology 5 How we gathered the data 5 Understanding the data
Recent Progress in In Vitro Fertilization and Intracytoplasmic Sperm Injection Technologies in Japan
Research and Reviews Recent Progress in In Vitro Fertilization and Intracytoplasmic Sperm Injection Technologies in Japan JMAJ 52(1): 29 33, 2009 Kaoru YANAGIDA* 1 Abstract The three basic pillars of fertility
Risks and complications of assisted conception
Risks and complications of assisted conception August 005 Richard Kennedy British Fertility Society Factsheet www.fertility.org.uk No medical treatment is entirely free from risk and infertility treatment
Fertility care for women diagnosed with cancer
Saint Mary s Hospital Department of Reproductive Medicine Fertility care for women diagnosed with cancer Information For Patients INF/DRM/NUR/16 V1/01/11/2013 1 2 Contents Page Overview 4 Our Service 4
Preimplantation Genetic Diagnosis (PGD) in Western Australia
Preimplantation Genetic Diagnosis (PGD) in Western Australia Human somatic cells have 46 chromosomes each, made up of the 23 chromosomes provided by the egg and the sperm cell from each parent. Each chromosome
Artificial insemination with donor sperm
Artificial insemination with donor sperm Ref. 123 / 2009 Reproductive Medicine Unit Servicio de Medicina de la Reproducción Gran Vía Carlos III 71-75 08028 Barcelona Tel. (+34) 93 227 47 00 Fax. (+34)
In Vitro Fertilization (IVF) Page 1 of 11
In Vitro Fertilization (IVF) Page 1 of 11 This document is a part of your informed consent process. Both partners should read the entire document carefully. In vitro fertilization (IVF) is a treatment
Reproduction and its Hormonal Control
Reproduction and its Hormonal Control Page 1 Reproduction and its Hormonal Control Different mammals have different patterns of reproduction Eg mammals, rats and mice can breed all year round, whereas
Illinois Insurance Facts Illinois Department of Insurance
Illinois Insurance Facts Illinois Department of Insurance Insurance Coverage for Infertility Treatment Revised December 2014 Note: This information was developed to provide consumers with general information
The IUI procedure Who should consider an IUI IUI success rates IUI cost What to consider if IUI is unsuccessful. The IUI procedure:
A Complete Guide to understanding IUI (intrauterine insemination) and artificial insemination (Eric Daiter, MD Board Certified in Reproductive Endocrinology and Infertility) The IUI procedure Who should
REPRODUCTIVE MEDICINE AND INFERTILITY ASSOCIATES Woodbury Medical Arts Building 2101 Woodwinds Drive Woodbury, MN 55125 (651) 222-6050
REPRODUCTIVE MEDICINE AND INFERTILITY ASSOCIATES Woodbury Medical Arts Building 2101 Woodwinds Drive Woodbury, MN 55125 (651) 222-6050 RECIPIENT COUPLE INFORMED CONSENT AND AUTHORIZATION FOR IN VITRO FERTILIZATION
Consultations & other investigations
Pricelist Please note as part of pre-treatment consultations, you may be required to have blood tests performed, the costs of which are not included in the treatment cycles. These costs are outlined below.
Assisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register
1 Assisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register Joanne Gunby, M.Sc. CARTR Co-ordinator Email: [email protected] Supported by the IVF Directors Group of
The following chapter is called "Follow-ups with a Positive or a Negative Pregnancy Test".
Slide 1 Welcome to chapter 7. The following chapter is called "Follow-ups with a Positive or a Negative Pregnancy Test". The author is Professor Pasquale Patrizio. Slide 2 This chapter has the following
COVENTRY HEALTH CARE OF ILLINOIS, INC. COVENTRY HEALTH CARE OF MISSOURI, INC. Medical Management Policy and Procedure PROPRIETARY
COVENTRY HEALTH CARE OF ILLINOIS, INC. COVENTRY HEALTH CARE OF MISSOURI, INC. Medical Management Policy and Procedure PROPRIETARY Policy: Infertility Evaluation and Treatment Number: MM 1306 Date Effective:
The cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatments Sykes D, Out H J, Palmer S J, van Loon J
The cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatments Sykes D, Out H J, Palmer S J, van Loon J Record Status This is a critical abstract of an economic evaluation that
IN VITRO FERTILISATION IVF and ICSI
IN VITRO FERTILISATION IVF and ICSI Page 1 of 7 WHAT ARE IVF and ICSI? IVF is short for in vitro fertilisation which means fertilisation outside the body. It usually involves stimulation of the ovaries
University Hospitals Coventry and Warwickshire NHS Trust. Centre for Reproductive Medicine. We Care. We Achieve. We Innovate.
University Hospitals Coventry and Warwickshire NHS Trust Centre for Reproductive Medicine We Care. We Achieve. We Innovate. Introduction We were the first NHS Hospital in the West Midlands to set up a
Egg Sharing Price list
Egg Sharing Price list IVF Egg Sharing with anonymous recipient COMPLETE PACKAGE S1 1500 An all-inclusive package for women who need IVF or ICSI treatment and choose to share their eggs with an anonymous
Anatomy and Physiology of Human Reproduction. Module 10a
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
ART - - - - - IVF - NO.1 IVF - IVF
The success of any ART laboratory depends on its IVF laboratory. The primary function of an ART laboratory is to provide an optimal environment for gametes and embryos. To set up an ART laboratory, the
FINANCIAL INFORMATION FOR PATIENTS
IVF Hammersmith Hammersmith Hospital Du Cane Road London W12 0HS Tel: 0203 313 4411 Fax: 0203 313 8534 www.ivfhammersmith.com IVF Hammersmith FINANCIAL INFORMATION FOR PATIENTS We hope this guide will
A POWERFUL IN VITRO FERTILIZATION
A POWERFUL During the past 50 years technological advances in the field of bovine reproduction have led to some dramatic changes in the way cattle look, reproduce, perform, and even taste. Artificial Insemination
Male Infertility and Assisted Reproductive Technology: Lessons from the IVF
138 The Open Reproductive Science Journal, 2011, 3, 138-153 Open Access Male Infertility and Assisted Reproductive Technology: Lessons from the IVF Sandro C. Esteves * and Danielle T. Schneider ANDROFERT,
it right? activity (page 4) to highlight ethical issues associated with IVF
IN VITRO FERTILIZATION I V F In some cases, a sperm is directly injected into an egg IVF: THE MEETING OF SPERM AND EGG IN GLASS Louise Brown, the first test tube baby was born in 1978. Since then, there
Assisted reproductive technology in Australia and New Zealand 2010
Assisted reproductive technology in Australia and New Zealand 2010 ASSISTED REPRODUCTION SERIES Number 16 Assisted reproductive technology in Australia and New Zealand 2010 Alan Macaldowie Yueping A Wang
How to Find Out What s Wrong A BASIC GUIDE TO MALE. A doctor s guide for patients developed by the American Urological Association, Inc.
A BASIC GUIDE TO MALE How to Find Out What s Wrong A doctor s guide for patients developed by the American Urological Association, Inc. Based on the AUA Best Practice Policy and ASRM Practice Committee
Consent for Frozen Donor Oocyte In Vitro Fertilization and Embryo Transfer (Recipient)
Name of Patient: Name of Partner: We, the Patient and Partner (if applicable) named above, are each over the age of twenty-one (21) years. By our signatures below, I/we request and authorize the performance
European IVF Monitoring (EIM) Year: 2008
European IVF Monitoring (EIM) Year: 2008 Name of country POLAND Name and full address of contact person. professor Rafal Kurzawa MD PhD Fertility and Sterility Special Interest Group Polish Gynaecological
Areas of Concern. Reproductive Ethics: Issues &
Reproductive Ethics: Issues & Areas of Concern Conception Control: under what conditions is conception control in harmony with a Christian ethic? Genetic Screening & Counseling: under what conditions should
INFORMED CONSENT AND AUTHORIZATION FOR IN VITRO FERTILIZATION OF PREVIOUSLY CRYOPRESERVED OOCYTES
INFORMED CONSENT AND AUTHORIZATION FOR IN VITRO FERTILIZATION OF PREVIOUSLY CRYOPRESERVED OOCYTES We, the undersigned, as patient and partner understand that we will be undergoing one or more procedures
AGE & FERTILITY: Effective Evaluation & Treatment I. LANE WONG, MD, FACOG. www.hopefertilitycenter.com www.hopeivf.com
Page 1 of 6 AGE & FERTILITY: Effective Evaluation & Treatment I. LANE WONG, MD, FACOG. www.hopefertilitycenter.com www.hopeivf.com Age has a profound effect on female fertility. This is common knowledge,
IVF Waiting Times in Scotland
IVF Waiting Times in Scotland Quarter ending 31 March 2016 Publication date 31 May 2016 An Official Statistics Publication for Scotland Key Points The Scottish Government have set a target that at least
Human Fertilisation and Embryology Authority. Minutes of the Statutory Approvals Committee
Human Fertilisation and Embryology Authority Minutes of the Statutory Approvals Committee Meeting held at Finsbury Tower, 103-105 Bunhill Row, London, EC1Y 8HF on 26 March 2015 Minutes item 6 Centre 0035
Fast Track to IVF. Objectives
Disclosure statement: Richard H. Reindollar, M.D. has no relevant financial relationships with any manufacturers of pharmaceuticals, laboratory supplies, or medical devices. Fast Track to IVF Richard H.
The Menstrual Cycle. Model 1: Ovarian Cycle follicular cells
The Menstrual Cycle REVIEW questions to complete before starting this POGIL activity 1. Gonads produce both gametes and sex steroid hormones. For the female, name the: A. gonads ovaries B. gametes oocyte/ovum/egg
a guide to Infertility
a guide to Infertility Welcome List of Contents Sims IVF has provided IVF treatment to couples in Ireland since 1997. Our aim now, as it was then, is to bring the joy of a family to those who need help
Consent to Perform Preimplantation Genetic Screening (PGS) using. Comparative Genomic Hybridization (acgh) or Next Generation Sequencing (NGS)
Consent to Perform Preimplantation Genetic Screening (PGS) using Array Comparative Genomic Hybridization (acgh ) or Next Generation Sequencing (NGS) Purpose The purpose of Preimplantation Genetic Screening
Midland Fertility Services Blastocyst Transfer
Midland Fertility Services Blastocyst Transfer Building futures, transforming lives What is a blastocyst? When a sperm fertilises an egg the resulting embryo develops from the original single cell into
Understanding Fertility
Understanding Fertility 6 Introduction The word fertile means the ability to become pregnant or to cause pregnancy. Basic knowledge of both the male and female reproductive systems is important for understanding
Sexuality after your Spinal Cord Injury
Sexuality after your Spinal Cord Injury Introduction Spinal Cord Injury (SCI) affects to varying degrees the mechanics and sensations of sex and sexuality. Some people think that spinal injury means an
Carol Ludowese, MS, CGC Certified Genetic Counselor HDSA Center of Excellence at Hennepin County Medical Center Minneapolis, Minnesota
Carol Ludowese, MS, CGC Certified Genetic Counselor HDSA Center of Excellence at Hennepin County Medical Center Minneapolis, Minnesota The information provided by speakers in workshops, forums, sharing/networking
Center for Women s Reproductive Care at Columbia University
Center for Women s Reproductive Care at Columbia University Oocyte Recipients Greetings, Thank you for your interest in the Center for Women s Reproductive Care at Columbia University. We hope that the
Age and Fertility. A Guide for Patients PATIENT INFORMATION SERIES
Age and Fertility A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of the Patient Education Committee and the Publications
Endometriosis, Fertility and Pregnancy
This leaflet covers endometriosis and fertility. It provides information for women who have been diagnosed with endometriosis who would like to know if and how this can affect their fertility, and for
Outline. Objective(s) Background. Methods. Results. Discussion. Questions
Outline Objective(s) Background Methods Results Discussion Questions Objectives To evaluate if psychological stress varies with the phase of in vitro fertilization treatment To determine if socio-demographic
European IVF Monitoring (EIM) Year: 2010
European IVF Monitoring (EIM) Year: 2010 Name of country: Poland Name and full address of contact person: Professor Rafal Kurzawa, MD PhD Fertility and Sterility Special Interest Group Polish Gynaecological
Informed Consent Packet - In Vitro Fertilization (IVF)
Center for Reproductive Medicine (CRM) Informed Consent Packet - In Vitro Fertilization (IVF) This packet contains the required IVF treatment consent documents. Please read, consider and, if you agree,
Nordic Fertility Society. Quality Guide. Checklist for ART Clinic and ART laboratory
Nordic Fertility Society Quality Guide Checklist for ART Clinic and ART laboratory Yes, not-applicable, No CLINICAL CHECK LIST PATIENT INFORMATION Is there a printed patient information on: Ovarian Stimulation?
THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT FOR IN VITRO FERTILIZATION AND EMBRYO TRANSFER
THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT FOR IN VITRO FERTILIZATION AND EMBRYO TRANSFER Partner #1 Last Name (Surname): Partner #1 First Name: Partner #1 Last 5 Digits
Biology and Society Unit Five: Human Reproduction Topic Four: Assisted Reproductive Technologies (ART)
Biology and Society Unit Five: Human Reproduction Topic Four: Assisted Reproductive Technologies (ART) Carl Djerassi (1923 - ) Excerpt from Sex in an Age of Mechanical Reproduction by Carl Djerassi With
ASSESSING DECISION TREE MODELS FOR CLINICAL IN VITRO FERTILIZATION DATA
ASSESSING DECISION TREE MODELS FOR CLINICAL IN VITRO FERTILIZATION DATA Technical Report TR03 296 Dept. of Computer Science and Statistics University of Rhode Island LEAH PASSMORE 1, JULIE GOODSIDE 1,
Balanced. translocations. rarechromo.org. Support and Information
Support and Information Rare Chromosome Disorder Support Group, G1, The Stables, Station Rd West, Oxted, Surrey. RH8 9EE Tel: +44(0)1883 723356 [email protected] I www.rarechromo.org Balanced Unique
Fertility-related choices. A decision aid for younger women with early breast cancer
Fertility-related choices A decision aid for younger women with early breast cancer Fertility-related choices Section 1 About this booklet 1 Overview 3 Summary of fertility options 4 Section 2 Some background
Centre for Preimplantation Genetic Diagnosis. Genetic testing. Care. Excellence. Support. Advice PGD
Centre for Preimplantation Genetic Diagnosis Genetic testing Care Excellence Support Advice PGD Contents Welcome to the Centre for Preimplantation Genetic Diagnosis 3 The PGD team 3 Counselling 4 What
Training Programme in. Assisted Reproductive Technologies:
Training Programme in Assisted Reproductive Technologies: In vitro Fertilisation & Embryo Transfer (IVF-ET) and Intra-Cytoplasmic Sperm Injection (ICSI) Published By: Trivector Embryo Support Academy (TESA)
Act of 5 December 2003 No. 100 relating to the application of biotechnology in human medicine, etc
Act of 5 December 2003 No. 100 relating to the application of biotechnology in human medicine, etc Cf. earlier Acts of 5 August 1994 No. 56 and 12 June 1987 No. 68 Chapter 1. Purpose and scope 1-1. Purpose
Management of Human Fertility Treatments in Healthcare
Management of Human Fertility Treatments in Healthcare SANIT PROJECT December 2003 Alphee Beauchamp Anthony Morris Introduction Demand for human fertility treatments is rising rapidly, fuelled by socio-demographic
Basics of infertility Student Lecture Dr. A. Vilos, MD, FRCSC, Ass. Professor Department of OB/Gyn, REI Division Western University
Definitions Basics of infertility Student Lecture Dr. A. Vilos, MD, FRCSC, Ass. Professor Department of OB/Gyn, REI Division Western University Infertility One year of frequent unprotected intercourse
